Premorbid warfarin use and lower D-dimer levels are associated with a spontaneous early improvement in an atrial fibrillation-related stroke

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 11, 2012, Pages 2394-2396

  Yoon, C W ^a   Kim, S J ^a   Bang, O Y ^a   Chung, C S ^a   Lee, K H ^a   Kim, G M ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER; WARFARIN;

ANTICOAGULANT THERAPY; APHASIA; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DYSARTHRIA; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; PARESIS; PRIORITY JOURNAL; SENSORY DYSFUNCTION;

AGED; ALGORITHMS; ATRIAL FIBRILLATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; ROC CURVE; STROKE; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WARFARIN;

EID: 84868122909     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04909.x     Document Type: Letter

References (8)

1. Minematsu K, Yamaguchi T, Omae T. 'Spectacular shrinking deficit'. Neurology 1992; 42: 157-62.
2. Kimura K, Minematsu K, Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15 831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 679-83.
3. Nedeltchev K, Schwegler B, Haefeli T, Brekenfeld C, Gralla J, Fischer U, Arnold M, Remonda L, Schroth G, Mattle HP. Outcome of stroke with mild or rapidly improving symptoms. Stroke 2007; 38: 2531-5.
4. Baumann CR, Baumgartner RW, Gandjour J, von Büdingen HC, Siegel AM, Georgiadis D. Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke 2006; 37: 1332-3.
5. Sadanaga T, Sadanaga M, Ogawa S. Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. J Am Coll Cardiol 2010; 55: 2225-31.
6. Lip G, Lowe G. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci 1995; 89: 205-14.
7. Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, Hasegawa D, Matsuda O. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28: 2217-22.
8. Lip G, Lowe G, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 1995; 73: 527-33.